Development of novel bepotastine salicylate salt bioequivalent to the commercial bepotastine besilate in beagle dogs

References

• Lyseng-Williamson KA. (2010). Oral bepotastine: in allergic disorders. Drugs, 70:1579–1591.
   PubMed Web of Science ®Google Scholar
• Williams JI, Gow JA, Klier SM, McCue SL, Salapatek AM, McNamara TR. (2010). Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate. Curr Med Res Opin, 26:2329–2338.
   PubMed Web of Science ®Google Scholar
• Williams JI, Kennedy KS, Gow JA, Torkildsen GL, Abelson MB, Gomes PJ et al.; Bepotastine Besilate Ophthalmic Solutions Study Group. (2011). Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis. J Ocul Pharmacol Ther, 27:385–393.
   PubMed Web of Science ®Google Scholar
• Otsuka M, Tanabe H. (2012). Stability test for amorphous materials in humidity controlled 96-well plates by near-infrared spectroscopy. Drug Dev Ind Pharm, 38:380–385.
   PubMed Web of Science ®Google Scholar
• Loeser E, Sutton P, Skorodinsky A, Lin M, Yowell G. (2012). Chemical interactions between an active pharmaceutical ingredient and its counterion in a tromethamine salt under forced degradation conditions. Drug Dev Ind Pharm, 38:357–364.
   PubMed Web of Science ®Google Scholar
• Loeser E, Sutton P, Skorodinsky A, Lin M, Yowell G. (2012). Chemical interactions between an active pharmaceutical ingredient and its counterion in a tromethamine salt under forced degradation conditions. Drug Dev Ind Pharm, 38:357–364.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). (2000). FDA guidance for industry on bioavailability and bioequivalence studies for orally administered drug products. Silver Spring, MD: U.S. Food and Drug Administration.
   Google Scholar
• Society of Toxicology (SOT). (2008). Guiding principles in the use of animals in toxicology. www.toxicology.org/AI/FA/guidingprinciples.pdf
   Google Scholar
• Kim YI, Kim KS, Suh KH, Shanmugam S, Woo JS, Yong CS et al. (2011). New clopidogrel napadisilate salt and its solid dispersion with improved stability and bioequivalence to the commercial clopidogrel bisulphate salt in beagle dogs. Int J Pharm, 415:129–139.
   PubMed Web of Science ®Google Scholar
• Park YJ, Xuan JJ, Oh DH, Balakrishnan P, Yang HJ, Yeo WH et al. (2010). Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability. Arch Pharm Res, 33:1217–1225.
   PubMed Web of Science ®Google Scholar
• Joe JH, Lee WM, Park YJ, Joe KH, Oh DH, Seo YG et al. (2010). Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int J Pharm, 395:161–166.
   PubMed Web of Science ®Google Scholar
• Kim BH, Chung JY, Kim JR, Lim KS, Lim HS, Yu KS, Jang IJ, Shin SG. (2007). Pharmacokinetic characteristics of bepotastine besilate in healthy subjects. Kor J Clin Pharmacol Ther, 15:37–45.
   Google Scholar
• Amighi K, Timmermans J, Puigdevall J, Baltes E, Moës AJ. (1998). Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation. Drug Dev Ind Pharm, 24:509–515.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK et al. (2007). Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm, 343:228–237.
   PubMed Web of Science ®Google Scholar
• Li DX, Oh YK, Lim SJ, Kim JO, Yang HJ, Sung JH et al. (2008). Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique. Int J Pharm, 355:277–284.
   PubMed Web of Science ®Google Scholar
• Oh DH, Park YJ, Kang JH, Yong CS, Choi HG. (2011). Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Deliv, 18:46–53.
   PubMed Web of Science ®Google Scholar
• Cho KH, Choi YK, Kang JH, Choi HG, Yong CS, Park YJ. (2010). Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia. Int J Pharm, 400:145–152.
   PubMed Web of Science ®Google Scholar
• Lim HT, Balakrishnan P, Oh DH, Joe KH, Kim YR, Hwang DH et al. (2010). Development of novel sibutramine base-loaded solid dispersion with gelatin and HPMC: physicochemical characterization and pharmacokinetics in beagle dogs. Int J Pharm, 397:225–230.
   PubMed Web of Science ®Google Scholar
• Yan YD, Kim DH, Sung JH, Yong CS, Choi HG. (2010). Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. Int J Pharm, 399:116–120.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Lundqvist A, Strimfors M. (2011). Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor – the importance of gastrointestinal pH and solubility for the in vivo exposure. Drug Dev Ind Pharm, 37:1036–1042.
   PubMed Web of Science ®Google Scholar
• Medendorp J, Donovan B, Pennington J. (2010). Development of a high-throughput UHPLC-MS-based content uniformity method as a tool for assessing dry powder inhalers. Drug Dev Ind Pharm, 36:762–772.
   PubMed Web of Science ®Google Scholar
• Kanaujia P, Lau G, Ng WK, Widjaja E, Schreyer M, Hanefeld A et al. (2011). Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy. Drug Dev Ind Pharm, 37:1026–1035.
   PubMed Web of Science ®Google Scholar
• Gould PL. (1986). Salt selection for basic drugs. Int J Pharm, 33:201–217.
   Web of Science ®Google Scholar
• David SE, Timmins P, Conway BR. (2012). Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs. Drug Dev Ind Pharm, 38:93–103.
   PubMed Web of Science ®Google Scholar
• Lee T, Wang YW. (2009). Initial salt screening procedures for manufacturing ibuprofen. Drug Dev Ind Pharm, 35:555–567.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Greenlees KJ. (2003). Animal drug human food safety toxicology and antimicrobial resistance – the square peg. Int J Toxicol, 22:131–134.
   PubMed Web of Science ®Google Scholar
• Kroes R, Kozianowski G. (2002). Threshold of toxicological concern (TTC) in food safety assessment. Toxicol Lett, 127:43–46.
   PubMed Web of Science ®Google Scholar